Colon cancer blood test offers new screening option
Time:2024-05-21 14:12:06 Source:opinionsViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
You may also like
- I was 'brokefished' by my friend for £400
- Here are 14 players to watch next season across the Big Ten Conference
- Windmill sails at Moulin Rouge have collapsed
- Naomi Watts, 55, proves she's in the best shape of her life as she flexes her eye
- Kristin Cavallari, 37, ignores critics of her age
- Washington Commanders will retire Hall of Fame cornerback Darrell Green's No. 28 next season
- Woman, 43, accused of murdering her disabled mother
- Technical glitch temporarily closed southern Norway airspace, causing delays at Oslo airport
- ‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad